EFFETCS OF MİNDFULNESS-BASED STRESS REDUCTION İN WOMEN WİTH CORONARY ARTERY DİSEASE
MBSR-CADWOMEN
THE EFFECT OF A MINDFULNESS-BASED STRESS REDUCTION PROGRAM ON QUALITY OF LIFE , ANXIETY AND EMPOWERMENT LEVELS IN WOMEN WITH CORONARY ARTERY DISEASE
1 other identifier
interventional
70
1 country
1
Brief Summary
Coronary artery disease (CAD) is a common cardiovascular condition characterized by the narrowing or blockage of the coronary arteries that supply oxygen-rich blood to the heart muscle. CAD represents a significant cause of morbidity and mortality, particularly among individuals aged 40 and older, affecting millions of men and women worldwide. Patients with CAD experience not only physical symptoms but also psychological challenges, including stress and anxiety, which can negatively impact quality of life. In recent years, mindfulness-based interventions have emerged as scientifically supported approaches to help individuals with chronic diseases manage stress and enhance emotional regulation skills. While the existing literature includes studies evaluating the effects of mindfulness-based interventions in CAD and other cardiovascular conditions, most investigations address mixed patient populations and do not thoroughly examine sex-specific differences. Notably, women with CAD may experience symptoms and psychological effects differently than men. Therefore, there is a need for tailored, comprehensive intervention models that address the multidimensional needs of female patients, including stress management, anxiety reduction, and empowerment. This study aims to evaluate the effectiveness of mindfulness-based interventions in women with CAD, providing a targeted approach that addresses both clinical and psychosocial outcomes. The findings are expected to offer valuable insights into improving quality of life and enhancing coping strategies for women living with chronic cardiovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2026
CompletedFirst Posted
Study publicly available on registry
January 28, 2026
CompletedStudy Start
First participant enrolled
April 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 15, 2026
January 29, 2026
January 1, 2026
2 months
January 20, 2026
January 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cardiac Quality of Life Scale
The Heart Quality of Life Scale (HeartQoL) is a reliable instrument developed to assess quality of life in individuals with ischemic heart disease (Oldridge, 2014). The scale consists of 14 items, with 10 assessing physical aspects and 4 assessing emotional aspects. Each item is scored from 0 to 3, with higher scores indicating better quality of life. It can be applied to individuals aged 18 and above. Turkish validity and reliability were established by Duğan (2018).
Baseline and at the end of the 8-week program
Secondary Outcomes (1)
State-Trait Anxiety Inventory - Short Form (STAI-SF)
Baseline and at the end of the 8-week program
Other Outcomes (1)
Coronary Artery Disease Empowerment Scale
Baseline and at the end of the 8-week program
Study Arms (2)
Mindfulness-Based Intervention Group
EXPERIMENTALParticipants in the intervention group will take part in an 8-week mindfulness-based program designed to cultivate awareness related to anxiety, psychological resilience, and quality of life in women with coronary artery disease.
Standard Care in Women with Coronary Artery Disease
NO INTERVENTIONParticipants in the control group will receive standard care, including routine medical follow-up and discharge education, without any structured intervention.
Interventions
This intervention is an 8-week structured mindfulness-based program designed to cultivate awareness related to anxiety, psychological resilience, and quality of life in women with coronary artery disease. The program includes meditation, breathing, and mindfulness exercises, distinguishing it from the standard care received by the control group.
Eligibility Criteria
You may qualify if:
- Diagnosed with coronary artery disease (CAD) for at least 1 month.
- Score of 14 or higher on the Short Form of the State-Trait Anxiety Inventory (STAI-SF) at baseline.
- At least primary school education.
- Age between 18 and 50 years.
- Sexually active.
- Having an active social network.
You may not qualify if:
- Individuals with hearing or language impairments that would hinder communication.
- Women who have entered menopause.
- Women with psychiatric disorders.
- Discontinuation Criteria:
- Participants who choose to withdraw from the study.
- Participants who miss two intervention sessions.
- Participants with incomplete data on study forms.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TC Erciyes Universitylead
- Kayseri City Hospitalcollaborator
Study Sites (1)
Kayseri Şehir Hastanesi
Kayseri, Türki̇ye, 38000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- HATİCE PENEKLİ, PhD Candidate, Faculty of Nursing, Institute of Health Sciences, Erciyes University
Study Record Dates
First Submitted
January 20, 2026
First Posted
January 28, 2026
Study Start
April 15, 2026
Primary Completion (Estimated)
June 15, 2026
Study Completion (Estimated)
October 15, 2026
Last Updated
January 29, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual participant information will not be shared at this time, as the study has not yet started and confidentiality must be maintained.